Page last updated: 2024-09-03

methylthio-adp and Diabetes Mellitus, Type 1

methylthio-adp has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Taguchi, K1

Other Studies

1 other study(ies) available for methylthio-adp and Diabetes Mellitus, Type 1

ArticleYear
Mechanisms underlying reduced P2Y(1) -receptor-mediated relaxation in superior mesenteric arteries from long-term streptozotocin-induced diabetic rats.
    Acta physiologica (Oxford, England), 2013, Volume: 207, Issue:1

    Topics: Adenosine Diphosphate; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Models, Animal; Male; Mesenteric Artery, Superior; Nitric Oxide; Nitric Oxide Synthase Type III; Purinergic P2Y Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2Y1; Signal Transduction; Thionucleotides; Time; Vasodilation

2013